Tiziana Life Sciences announces last patient completes visit in Inform-ms trial of intranasal foralumab

Tiziana Life Sciences Ltd said on Thursday that the last patient has completed their final visit in the company's Phase 2a Inform-ms clinical trial of its intranasal foralumab.